Inve India ▾

KRM Ayurveda share price & results

KRM Ayurveda Ltd· Healthcare

Results to
Jun 2026
Latest analysed call
Q4 FY26
Ownership as of
Sept 2026

Integrated Ayurveda healthcare group running hospitals, specialty clinics and teleconsultation, backed by an in-house GMP/ISO-certified plant making proprietary Ayurvedic formulations sold via D2C/e-commerce.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue32.3 ₹ crore+31.0% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin37.2 %+12.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit9.1 ₹ crore+124.2% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equityUnavailable−31.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.
Free cash flow margin0.09 %+2.3 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)Unavailable+17.5 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

10 targets tracked, none judged yet · 10 open · verdicts reflect calls analysed to Q4 FY26.

KRM Ayurveda Ltd management guidance track record on Inve: 10 targets tracked across analysed earnings calls (0 achieved, 0 missed, 10 open).

TargetOriginal wordingSaidLatest callVerdict
Revenue Growthat least 50% revenue growth
Call transcript, Q4 FY26 · 5 May 2026		Q4 FY26Q4 FY26:Therefore, we are moving ahead with a target of achieving at least 50% revenue growth.
Call transcript, Q4 FY26 · 5 May 2026		New

Source: Inve Guidance Tracker for KRM Ayurveda Ltd · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

10 of KRM Ayurveda Ltd's 10 targets are still open. See which are on track and which have gone quiet. The 1 above are the free sample; 9 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹230.15 −0.32% · −₹0.75

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance +27.4% YTD

₹150₹200₹250₹300JanMarAprMayJunJulAugSeptQ4 FY26 — 5 May 2026

YTD: ₹180.7 on 29 Jan 2026 → ₹230.15. High ₹329.8 (10 Aug 2026), low ₹160.55 (2 Feb 2026).

Previous close
₹230.9
Market cap
₹498 Cr
52-week range
₹160.55 – ₹329.8
Price to earnings (FY ending Mar 2026)
24.90×
Return on equity (FY ending Mar 2026)
28.95%

Overview

Symbol
NSE:KRMAYURVED
Exchange
NSE
Currency
INR

What KRM Ayurveda Ltd does

Based on the company's own presentations, annual report and earnings calls.

KRM Ayurveda began in 2019 as a kidney-specialty hospital in Delhi and has since expanded into a multi-specialty Ayurvedic healthcare group. It runs hospitals and clinics offering in-patient and out-patient Ayurvedic care, Panchakarma and other wellness therapies, staffed by BAMS-qualified physicians and certified therapists. It also manufactures classical and proprietary Ayurvedic formulations (capsules, tablets, syrups, oils) at a GMP- and ISO-certified unit in Kundli, Haryana, which it sells through a D2C/e-commerce channel and promotes via a large YouTube following, alongside teleconsultation services for patients globally.

Segments

  • Hospitals & Clinics
  • Product Manufacturing
  • D2C, E-commerce & Telehealth
Hospitals
6
Specialty clinics
8
Bed capacity
223 beds (as on Mar 2026)
Average bed occupancy
69%
Ayurvedic physicians
40+ (BAMS, CCIM-recognized)
Manufacturing facility
1 GMP & ISO-certified unit (Kundli, Haryana)
Founded 2019Headquarters New Delhi, India Company website

How the price took the results

close before → close after

Q4 FY26
+8.6%
5 May

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for KRM Ayurveda Ltd

Free account: one company. Everything above stays public.

Write why you follow KRM Ayurveda Ltd and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse KRM Ayurveda Ltd

Guides on how to read this kind of business and the numbers that matter.